0001235802-23-000041.txt : 20230418 0001235802-23-000041.hdr.sgml : 20230418 20230418163059 ACCESSION NUMBER: 0001235802-23-000041 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230418 DATE AS OF CHANGE: 20230418 EFFECTIVENESS DATE: 20230418 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DiaMedica Therapeutics Inc. CENTRAL INDEX KEY: 0001401040 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: Z4 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-479300 FILM NUMBER: 23827209 BUSINESS ADDRESS: STREET 1: 301 CARLSON PARKWAY STREET 2: SUITE 210 CITY: MINNEAPOLIS STATE: MN ZIP: 55305 BUSINESS PHONE: (763) 496-5454 MAIL ADDRESS: STREET 1: 301 CARLSON PARKWAY STREET 2: SUITE 210 CITY: MINNEAPOLIS STATE: MN ZIP: 55305 FORMER COMPANY: FORMER CONFORMED NAME: DiaMedica Inc. DATE OF NAME CHANGE: 20070525 D 1 primary_doc.xml X0708 D LIVE 0001401040 DiaMedica Therapeutics Inc. 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN MINNESOTA 55305 (763) 496-5454 CANADA (FEDERAL LEVEL) DiaMedica Inc. Corporation true Rick Pauls 301 Carlson Parkway, Suite 210 Minneapolis MN MINNESOTA 55305 Executive Officer Director Scott Kellen 301 Carlson Parkway, Suite 210 Minneapolis MN MINNESOTA 55305 Executive Officer Dominic Cundari 301 Carlson Parkway, Suite 210 Minneapolis MN MINNESOTA 55305 Executive Officer Julie Daves 301 Carlson Parkway, Suite 210 Minneapolis MN MINNESOTA 55305 Executive Officer Kirsten Gruis 301 Carlson Parkway, Suite 210 Minneapolis MN MINNESOTA 545305 Executive Officer R. Michael Giuffre 301 Carlson Parkway, Suite 210 Minneapolis MN MINNESOTA 55305 Director Tanya N. Lewis 301 Carlson Parkway, Suite 210 Minneapolis MN MINNESOTA 55305 Director James T. Parsons 301 Carlson Parkway, Suite 210 Minneapolis MN MINNESOTA 55305 Director Richard D. Pilnik 301 Carlson Parkway, Suite 210 Minneapolis MN MINNESOTA 55305 Director Charles P. Semba 301 Carlson Parkway, Suite 210 Minneapolis MN MINNESOTA 55305 Director Biotechnology Decline to Disclose 06b false 2023-04-10 false true false 0 750000 750000 0 false 1 0 0 0 false DiaMedica Therapeutics Inc. /s/ Scott Kellen Scott Kellen Chief Financial Officer and Secretary 2023-04-18